TABLE 1.

Clinical and demographic baseline characteristics in DCD and EPD groups.

Variables	Class II DCD group (n = 18)	Class III DCD group (n = 18)	EPD group (n = 22)	p value
Donor age (years) (m ± SD)	49.6 ± 7.94	54.89 ± 8.7	48 ± 11.9	p = 0.08
Recipient age (years) (m ± SD)	55.89 ± 10.9	55.61 ± 8.7	50.86 ± 10.34	p = 0.25
Donor BMI (m ± SD)	27.05 ± 3.4	26.48 ± 3.65	26.51 ± 2.8	p = 0.85
Recipient BMI (m ± SD	25.02 ± 5.1	24.75 ± 3.58	23.33 ± 3.24	p = 0.37
Donor gender (%)				p = 0.7
Male	79.4	75.1	86.3
Female	22.6	24.9	13.7
Recipient gender (%)				p = 0.46
Male	66.6	62.5	68.1
Female	33.4	37.5	31.9
Donor comorbidity (%)
Diabetes	5.5	7.3	9	p = 0.6
Hypertension	28.7	29.5	23.6	p = 0.32
Cardiovascular disease	27.5	23.5	31.8	p = 0.07
Dyslipidemia	16.6	17.7	15.6	p = 0.69
Current smoking	21.7	22	20	p = 0.1
Recipient comorbidity (%)
Diabetes	5	6	3	p = 0.52
Hypertension	77.7	72.3	60.0	p = 0.11
Cardiovascular disease	22.2	18	19.9	p = 0.42
Dyslipidemia	8.3	10	10.1	p = 0.40
Current smoking	19.4	8	10	p = 0.50
Recipient dialytic age (months) (mean ± SD)	39 ± 5.3	37 ± 8	42.8 ± 5.8	p = 0.42
HLA D/R matches (median and IQR)	2 (1–3)	2 (1–3.7)	2 (1–2,25)	p = 0.7
Maximum panel reactive antibody (median; min-max)	0 (0–65)	0 (0–50)	0 (0–65)	p = 0.49
Primary renal disease (%)
Polycystic kidney disease	19.4	24.5	30.3	p = 0.5
Glomerulonephritis	25.8	18.8	8.6	p = 0.13
Nephroangiosclerosis	29	29	22.2	p = 0.74
Unknown	6.5	10.5	27.8	p = 0.10
Miscellaneous	19.3	17.2	11.1	p = 0.12